Patents by Inventor Matthias Bräutigam

Matthias Bräutigam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • L-DOPA DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISEASES
    Publication number: 20190224153
    Abstract: The present invention describes a new method and new combination products for the therapy of neurological and other conditions which respond to dopaminergic therapies and especially to L-DOPA (L-Dihydroxy-Phenylalanine) based on the use of L-DOPA esters, especially of L-DOPA glycerol ester and L-DOPA Cholin Ester.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 25, 2019
    Inventors: Johannes TACK, Christoph VOELKEL, Reinhard HOROWSKI, Matthias BRAEUTIGAM, Dirk PALLA
  • USE OF HIGH-DOSES OF MONOMERIC CONTRAST MEDIUM CONTAINING IODINE IN X-RAY DIAGNOSTICS, IN PARTICULAR IN INTERVENTIONAL X-RAY DIAGNOSTICS AND IN RADIATION THERAPY ASSISTED BY CONTRAST MEDIA CONTAINING IODINE
    Publication number: 20120134933
    Abstract: The invention relates to a diagnostic or therapeutic composition comprising a monomeric X-ray contrast medium containing iodine, in particular iopromide, for use in an X-ray assisted diagnosis or therapy and for the use of high doses of an X-ray contrast medium given to a patient, in particular patients with restricted kidney function.
    Type: Application
    Filed: May 6, 2010
    Publication date: May 31, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Gregor Jost, Hubertus Pietsch, Martin Sieber, Matthias Bräutigam, Sven Golfier